Copyright
©The Author(s) 2019.
World J Gastroenterol. Oct 7, 2019; 25(37): 5687-5701
Published online Oct 7, 2019. doi: 10.3748/wjg.v25.i37.5687
Published online Oct 7, 2019. doi: 10.3748/wjg.v25.i37.5687
Figure 4 Kaplan-Meier’s recurrence-free survival probabilities of the downstaging group and the bridging group.
Time zero represents the orthotopic liver transplant date. The difference in recurrence-free survival was not statistically significant (P = 0.935).
- Citation: Affonso BB, Galastri FL, da Motta Leal Filho JM, Nasser F, Falsarella PM, Cavalcante RN, de Almeida MD, Felga GEG, Valle LGM, Wolosker N. Long-term outcomes of hepatocellular carcinoma that underwent chemoembolization for bridging or downstaging. World J Gastroenterol 2019; 25(37): 5687-5701
- URL: https://www.wjgnet.com/1007-9327/full/v25/i37/5687.htm
- DOI: https://dx.doi.org/10.3748/wjg.v25.i37.5687